Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

11160	Companies
246377	Keywords
174358	Articles
133067	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 09/25/2025 at 10:46, 1 year ago

EQS-Adhoc: Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment
Heidelberg Pharma significantly reduces operating costs and focuses on lead ADC candidate HDP-101 due to delayed milestone payment. Extensive cost-saving measures implemented

Operating Costs Heidelberg Pharma Cost-saving Measures Milestone Payment ADC Candidate
BRIEF

published on 09/04/2025 at 09:51, 1 year 1 month ago

Heidelberg Pharma présentera de nouvelles données sur le HDP-101 lors de la réunion annuelle de l'IMS

Heidelberg Pharma HDP-101 Myélome Multiple Données Cliniques Réunion Annuelle De L'IMS
BRIEF

published on 09/04/2025 at 09:51, 1 year 1 month ago

Heidelberg Pharma to Present New HDP-101 Data at IMS Annual Meeting

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS Annual Meeting
PRESS RELEASE

published on 09/04/2025 at 09:46, 1 year 1 month ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
Heidelberg Pharma announces new clinical data for lead ATAC candidate HDP-101 to be presented at the International Myeloma Society Annual Meeting 2025

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate International Myeloma Society
BRIEF

published on 08/28/2025 at 03:55, 1 year 1 month ago

La FDA demande des données supplémentaires à Telix Pharmaceuticals, retardant ainsi le paiement à Heidelberg Pharma

Heidelberg Pharma Mise À Jour Réglementaire TLX250-CDx Conséquences Financières Demande De La FDA
BRIEF

published on 08/28/2025 at 03:55, 1 year 1 month ago

FDA Requests Additional Data from Telix Pharmaceuticals, Delaying Payment to Heidelberg Pharma

Heidelberg Pharma Regulatory Update TLX250-CDx FDA Request Financial Implications
PRESS RELEASE

published on 08/28/2025 at 03:50, 1 year 1 month ago

EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Heidelberg Pharma's partner Telix Pharmaceuticals faces delays in TLX250-CDx FDA approval. USD 70 million payment from HealthCare Royalty postponed. Current cash reach until Q1 2026

FDA Approval Heidelberg Pharma HealthCare Royalty Telix Pharmaceuticals TLX250-CDx
BRIEF

published on 07/10/2025 at 07:08, 1 year 3 months ago

Heidelberg Pharma's Promising Mid-Year 2025 Developments

Leadership Changes Royalty Agreement Financial Developments HDP-101 Trials HDP-102 Introduction
BRIEF

published on 07/10/2025 at 07:08, 1 year 3 months ago

Développements prometteurs de Heidelberg Pharma pour la mi-année 2025

Changements De Direction Évolution Financière Accord De Redevances Essais HDP-101 Présentation Du HDP-102
PRESS RELEASE

published on 07/10/2025 at 07:03, 1 year 3 months ago

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business
Heidelberg Pharma AG reports on positive first half-year 2025 business performance including advancements in ATAC candidates HDP-101 and HDP-102. Financial figures show promising results in line with planning

Financial Report Clinical Trials HDP-101 Heidelberg Pharma AG ATAC Candidates

Accesswire

Published on 10/12/2026 at 22:01, 3 hours 9 minutes ago

Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 10 hours 10 minutes ago

Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 12 hours 10 minutes ago

U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 20 hours ago

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 23 hours ago

BrandPilot AI Announces Closing of Previously Announced Debt Settlement

View all ACCESSWIRE

EQS Group

Published on 10/12/2026 at 20:30, 4 hours 40 minutes ago

Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 4 hours 40 minutes ago

Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 5 hours 5 minutes ago

SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 6 hours ago

Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 19:00, 6 hours 10 minutes ago

PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 5 octobre 2026 au 9 octobre 2026

Les Echos

Published on 10/12/2026 at 17:59, 7 hours 11 minutes ago

Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:59, 7 hours 11 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 7 au 9 octobre 2026
Published on 10/12/2026 at 17:45, 7 hours 25 minutes ago

Weekly share buyback
Published on 10/12/2026 at 17:45, 7 hours 25 minutes ago

Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 11/10/2026
Published on 10/12/2026 at 17:45, 7 hours 25 minutes ago

Déclaration hebdomadaire de rachat d'actions

View all LES ECHOS COMFI WIRE